Format

Send to

Choose Destination
See comment in PubMed Commons below
Front Pharmacol. 2014 Feb 17;5:13. doi: 10.3389/fphar.2014.00013. eCollection 2014.

Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea.

Author information

  • 1Department of Pharmaceutical Sciences, University of Utrecht Utrecht, Netherlands ; Scientific Affairs, Danone Research Palaiseau, France.
  • 2Ars Accessus Medica Amsterdam, Netherlands.
  • 3York Health Economics Consortium Limited, University of York York, UK.
  • 4Institute of Primary Care and Public Health, School of Medicine, Cardiff University Cardiff, UK.

Abstract

INTRODUCTION:

Antibiotic-associated diarrhea (AAD) is common and frequently more severe in hospitalized elderly adults. It can lead to increased use of healthcare resources. We estimated the cost-effectiveness of a fermented milk (FM) with probiotic in preventing AAD and in particular Clostridium difficile-associated diarrhea (CDAD).

METHODS:

Clinical effectiveness data and cost information were incorporated in a model to estimate the cost impact of administering a FM containing the probiotic Lactobacillus paracasei ssp paracasei CNCM I-1518 in a hospital setting. Preventing AAD by the consumption of the probiotic was compared to no preventive strategy.

RESULTS:

The probiotic intervention to prevent AAD generated estimated mean cost savings of £339 per hospitalized patient over the age of 65 years and treated with antibiotics, compared to no preventive probiotic. Estimated cost savings were sensitive to variation in the incidence of AAD, and to the proportion of patients who develop non-severe/severe AAD. However, probiotics remained cost saving in all sensitivity analyses.

CONCLUSION:

Use of the fermented dairy drink containing the probiotic L. paracasei CNCM I-1518 to prevent AAD in older hospitalized patients treated with antibiotics could lead to substantial cost savings.

KEYWORDS:

Clostridium difficile; antibiotic-associated diarrhea; cost effectiveness; hospitalized elderly; nutrition economics; probiotics

PMID:
24596556
PMCID:
PMC3926519
DOI:
10.3389/fphar.2014.00013
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Frontiers Media SA Icon for PubMed Central
    Loading ...
    Support Center